Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 25, 2015
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen
David Groheux, Lucie Biard, Sylvie Giacchetti, et al.
Clinical Breast Cancer
|
June 22, 2021
Intraoperative Radiotherapy for Breast Cancer in Elderly Women
S Ophie Guillerm, Edwige Bourstyn, Ramona Itti, et al.
Reproductive Biomedicine Online
|
January 25, 2016
Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies
Anne-Sophie Hamy, Raphaël Porcher, Sarah Eskenazi, et al.
Clinical Breast Cancer
|
November 30, 2019
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients
Bruno Cutuli, Claire Lemanski, Brigitte De Lafontan, et al.
Reproductive Biomedicine Online
|
September 24, 2014
Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone
Anne-Sophie Hamy, Raphaël Porcher, Caroline Cuvier, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2008
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer
David Groheux, Jean-Luc Moretti, Georges Baillet, et al.
Cancer
|
March 19, 2013
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy
David Groheux, Mathieu Hatt, Elif Hindié, et al.
Cancer Medicine
|
August 29, 2025
Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis
Aurelia Robert, Paul Gougis, Elise Dumas, et al.
Cancers
|
September 22, 2020
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC
Luca Campedel, Paul Blanc-Durand, Asker Bin Asker, et al.
Breast Cancer Research : BCR
|
May 14, 2013
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
Jacqueline Lehmann-Che, Anne-Sophie Hamy, Raphaël Porcher, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 25, 2015
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen
David Groheux, Lucie Biard, Sylvie Giacchetti, et al.
Clinical Breast Cancer
|
June 22, 2021
Intraoperative Radiotherapy for Breast Cancer in Elderly Women
S Ophie Guillerm, Edwige Bourstyn, Ramona Itti, et al.
Reproductive Biomedicine Online
|
January 25, 2016
Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies
Anne-Sophie Hamy, Raphaël Porcher, Sarah Eskenazi, et al.
Clinical Breast Cancer
|
November 30, 2019
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients
Bruno Cutuli, Claire Lemanski, Brigitte De Lafontan, et al.
Reproductive Biomedicine Online
|
September 24, 2014
Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone
Anne-Sophie Hamy, Raphaël Porcher, Caroline Cuvier, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2008
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer
David Groheux, Jean-Luc Moretti, Georges Baillet, et al.
Cancer
|
March 19, 2013
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy
David Groheux, Mathieu Hatt, Elif Hindié, et al.
Cancer Medicine
|
August 29, 2025
Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis
Aurelia Robert, Paul Gougis, Elise Dumas, et al.
Cancers
|
September 22, 2020
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC
Luca Campedel, Paul Blanc-Durand, Asker Bin Asker, et al.
Breast Cancer Research : BCR
|
May 14, 2013
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
Jacqueline Lehmann-Che, Anne-Sophie Hamy, Raphaël Porcher, et al.
Page
of 3